Elsevier

Biochemical Pharmacology

Volume 43, Issue 4, 18 February 1992, Pages 667-670
Biochemical Pharmacology

Carrier-mediated uptake of pravastatin by rat hepatocytes in primary culture

https://doi.org/10.1016/0006-2952(92)90228-BGet rights and content

Abstract

The transport mechanism of pravastatin, a new cholesterol-lowering drug, was compared in vitro with rat hepatocyte primary culture and mouse skin fibroblasts (L-cells). The uptake of 14C-labeled pravastatin by cultured hepatocytes was temperature- and dose-dependent. The temperature-dependent uptake as a function of [14C]pravastatin concentration showed saturation kinetics with Km = 32.2 μM and a maximal uptake rate of 68 pmol/mg protein/min. The uptake of pravastatin was inhibited significantly by metabolic inhibitors such as rotenone, oligomycin A, antimycin A, 2, 4-dinitrophenol and KCN. Unlabeled pravastatin as well as R-416 and R-195, structural analogues of pravastatin, effectively competed for the hepatic uptake of [14C]pravastatin at 37°. These results indicate that pravastatin is taken up by the liver by an active transport. In contrast, the transport of pravastatin by L-cells was temperature-independent and non-saturable, suggesting that the uptake of pravastatin by L-cells is mediated by passive diffusion. The marked difference in the uptake mechanism of pravastatin between hepatocytes and L-cells may account for a unique feature of this drug in that the uptake and inhibition of cholesterol biosynthesis occur selectively in the liver.

References (10)

There are more references available in the full text version of this article.

Cited by (71)

  • Statin effects on cholesterol micro-domains in brain plasma membranes

    2003, Biochemical Pharmacology
    Citation Excerpt :

    While simvastatin and lovastatin as lipophilic lactone pro-drugs [19] are assumed to affect the central nervous system by penetrating the BBB [20,21], pravastatin does not enter the brain [22]. In the periphery, pravastatin utilises active transport mechanisms for membrane passage [23]. Since the compound is undetectable in the CSF of healthy subjects [22], one might doubt that similar transport systems occur at the BBB.

View all citing articles on Scopus
View full text